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Background: The high-mobility-group (HMG) proteins are the most abundant non-histone chromatin-associated
proteins. HMG proteins are present at high levels in various undifferentiated tissues during embryonic development
and their levels are strongly reduced in the corresponding adult tissues, where they have been implicated in
maintaining and activating stem/progenitor cells. Here we deciphered the role of the high-mobility-group AT-hook
protein 2 (HMGA2) during lung development by analyzing the lung of Hmga2-deficient mice (Hmga2−/−).
Results: We found that Hmga2 is expressed in the mouse embryonic lung at the distal airways. Analysis of
Hmga2−/− mice showed that Hmga2 is required for proper cell proliferation and distal epithelium differentiation
during embryonic lung development. Hmga2 knockout led to enhanced canonical WNT signaling due to an
increased expression of secreted WNT glycoproteins Wnt2b, Wnt7b and Wnt11 as well as a reduction of the WNT
signaling antagonizing proteins GATA-binding protein 6 and frizzled homolog 2. Analysis of siRNA-mediated
loss-of-function experiments in embryonic lung explant culture confirmed the role of Hmga2 as a key regulator of
distal lung epithelium differentiation and supported the causal involvement of enhanced canonical WNT signaling
in mediating the effect of Hmga2-loss-of-fuction. Finally, we found that HMGA2 directly regulates Gata6 and thereby
modulates Fzd2 expression.
Conclusions: Our results support that Hmga2 regulates canonical WNT signaling at different points of the pathway.
Increased expression of the secreted WNT glycoproteins might explain a paracrine effect by which Hmga2-knockout
enhanced cell proliferation in the mesenchyme of the developing lung. In addition, HMGA2-mediated direct
regulation of Gata6 is crucial for fine-tuning the activity of WNT signaling in the airway epithelium. Our results are
the starting point for future studies investigating the relevance of Hmga2-mediated regulation of WNT signaling in
the adult lung within the context of proper balance between differentiation and self-renewal of lung stem/
progenitor cells during lung regeneration in both homeostatic turnover and repair after injury.
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The mouse lung arises from the anterior endoderm and
forms during five overlapping phases of lung deve-
lopment: embryonic (embryonic days post coitum (E) 9
to 12.5), pseudoglandular (E12.5 to E16.5), canalicular
(E16.5 to E17.5), saccular (E17.5 to post-natal day (P) 5)
and alveolar (P5 to P28) [1-3]. At the end of the embry-
onic phase, primary and secondary lung buds formation
has taken place and the embryonic lung consists of one* Correspondence: guillermo.barreto@mpi-bn.mpg.de
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reproduction in any medium, provided the orleft lobe and four right lobes. From E10.5 to E16.5, the
epithelium undergoes branching morphogenesis to form
the respiratory (bronchial) tree. In parallel to branching
morphogenesis, the airway epithelium differentiates from
a morphologically uniform cell population to different
specialized cell types, thereby establishing a proximal-
distal axis in the developing lung. However, most of the
differentiation occurs in the canalicular and saccular
phases (E16.5 to P5). The primitive lung epithelium
co-expresses several lineage markers including Clara
cell-specific 10 kDa protein (Scgb1a1, also CC10)
and surfactant-associated protein C (Sftpc, also SP-C).
Later in gestation (E16.5 onwards), Scgb1a1 is a markertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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defines the distal epithelium. In the adult lung these
markers are characteristic of distinct cell lineages,
Scgb1a1 of Clara cells and Sftpc of alveolar type II cells.
Only specific progenitor cells in the adult lung, bron-
chioalveolar stem cells (BASCs), co-express Scgb1a1 and
Sftpc [4].
Several evolutionarily conserved signaling pathways
have been implicated in different phases of embryonic
lung development. In particular, members of the fibro-
blast growth factor, bone morphogenetic protein, hedge-
hog/Gli, epidermal growth factor and wingless secreted
glycoprotein (WNT) families have been implicated in
lung morphogenesis and epithelial differentiation [2,5-7].
In addition, a well-organized and balanced interplay bet-
ween these signaling pathways and key transcription fac-
tors of lung development, including NK2 homeobox 1
(also known as thyroid transcription factor 1), forkhead
box protein A2 (also known as hepatocyte nuclear factor
3-beta) and GATA6, is required for proper lung forma-
tion [2,3,7]. GATA6 is the only member of the GATA
family of zinc finger transcription factors that is ex-
pressed in the distal epithelium of the developing lung
[8,9]. GATA6 is essential for branching morphogenesis
and regulates differentiation of distal lung epithelium
[9,10]. Moreover, GATA6 has been implicated in bloc-
king WNT signaling to control the balance between
BASC expansion and lung epithelial differentiation re-
quired for both lung development and regeneration [11].
High mobility group AT-hook protein 2 (HMGA2) is a
transcription regulator belonging to the family of HMG
proteins. HMG proteins are the most abundant non-
histone chromatin-associated proteins and regulate gene
expression by altering chromatin structure and recrui-
ting other proteins to the transcription regulatory com-
plex [12]. HMGA2 is present at high levels in various
undifferentiated tissues during embryonic development
and its levels are strongly reduced in the corresponding
adult tissues [12,13]. In addition, Hmga2 expression in
adult organs has been implicated in maintaining and ac-
tivating stem/progenitor cells in different tissues [14,15].
Here, we show that Hmga2 mRNA levels are high during
early stages of lung development, in which cells are un-
differentiated, and become reduced and restricted to the
distal airways as lung development progresses, coinci-
dent with cell differentiation. Analysis of the lung of
Hmga2-knockout (KO) mice [16] revealed enhanced
canonical WNT signaling that led to increased cell
proliferation, increased number of progenitor cells and
reduced differentiation of the distal airway epithelium.
Using a lung explants culture system, we confirmed the
causal involvement of WNT signaling mediating the
effect of Hmga2-loss-of-function (LOF) and showed that
Hmga2 is required for proper branching morphogenesisduring the formation of the bronchial tree. Furthermore,
we showed that Hmga2 regulates canonical WNT sig-
naling at different points of the pathway. Increased
expression of the secreted WNT glycoproteins might ex-
plain a paracrine effect by which Hmga2-KO enhanced
cell proliferation in the mesenchyme of the developing
lung. In addition, HMGA2-mediated direct regulation of
Gata6 is crucial for fine-tuning the activity of WNT sig-
naling in the airway epithelium.
Results
Hmga2 is expressed in the mouse embryonic lung at the
distal airways
To verify that Hmga2 is expressed during lung develop-
ment, quantitative reverse transcription PCR (qRT-PCR)
expression analysis was performed (Figure 1A). Hmga2
transcript was detected at E11.5, when the primary lung
buds have evaginated from the foregut and secondary
buds are forming as outgrowths from the primary lung
buds. Hmga2 expression progressively decreased during
the pseudoglandular stages of lung development (E12.5
to E16.5). Between the canalicular (E16.5 to E17.5) and
initial saccular stages (E17.5 to E18.5), the levels of
Hmga2 transcript increased again. Later in gestation
(saccular stages, E18.5 to P5), Hmga2 expression was
further reduced and reached a basal level of expression
that was maintained through the alveolar phase (P5 to
P28). Thus, Hmga2 mRNA levels were high during early
stages of lung development, in which cells are undif-
ferentiated, and decreased as lung development pro-
gressed, coincident with cell differentiation.
In situ hybridization expression pattern analysis in the
embryonic lung at E12.5 (Figure 1B), when branching
morphogenesis of the lung bud is proceeding rapidly to
establish the future bronchial tree, revealed that Hmga2
is ubiquitously expressed with higher levels of expression
at the tips of the growing lung buds. Interestingly,
Hmga2 expression became restricted to the distal lung
endoderm at E14.5. Consistently, immunostaining on
sections of the embryonic lung at E14.5 (Figure 1C) sup-
ported the presence of HMGA2 in cells of the distal lung
endoderm. Co-staining with an antibody specific for the
nuclear envelope protein lamin B1 (LMNB1) demon-
strated the nuclear localization of HMGA2. The ob-
served expression patterns in embryonic lung suggest a
role for HMGA2 in epithelial differentiation.
Hmga2 is required for proper differentiation of the distal
epithelium during lung development
To determine the role of Hmga2 during lung develop-
ment, we analyzed the embryonic lung of Hmga2-deficient
mice (Hmga2−/−) [16]. At E18.5, when the bronchial tree
is complete and the lung tissues are differentiating into
different cell types that will constitute the lung after birth,
Figure 1 Hmga2 is expressed in the mouse embryonic lung at the distal airways. (A) Hmga2 is expressed during embryonic lung
development. Hmga2 and Gapdh expression was monitored by quantitative RT-PCR in mouse embryonic lung at different days post coitum
(E11.5 to E18.5) and in mouse lung at different days after birth (P1 to P28). Rel nor exp, relative expression normalized to Tuba1a. Error bars show
the SEM (n = 4). (B) Hmga2 is expressed in the mouse embryonic lung at the distal airways. Hmga2 mRNA was detected in mouse embryonic
lung at E12.5 and E14.5 by in situ hybridization using an Hmga2-specific antisense RNA probe. Sense probe, negative control. Scale bars, 200 μm.
Square shows details at higher magnification. (C) HMGA2 localized in the cell nuclei of the embryonic lung. Fluorescence microscopy of embryonic
lung sections (E14.5) after double immunostaining using HMGA2- and LMNB1-specific antibodies. Nuclear staining with DAPI (blue). Squares as in B.
Scale bars, 40 μm.
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to-body-wet-weight ratio (Additional file 1: Figures S1A
and Figure 2A). Macroscopically, the embryonic lung of
Hmga2-KO mice at E18.5 had four lobes on the right side
and one lobe on the left, indicating that the earliest events
during lung development, specification of pulmonary
endoderm and primary branching morphogenesis, oc-
curred normally and do not require Hmga2. However,
histological analysis of the embryonic lung at this stage
(Figure 2B) revealed a marked increase of cell density in
the Hmga2−/− mice when compared with the wild-type
(WT) mice, suggesting increased cell proliferation. Fur-
thermore, immunostaining on sections of embryonic lung
(Figure 2C) using antibodies specific for the epithelial
marker pan-cytokeratin (KRT) and the mesenchymal
marker vimentin (VIM) showed a broader mesenchyme
and an irregularly shaped epithelium in Hmga2-KO mice
when compared to the WT mice. This suggests an expan-
sion of the mesenchyme at the expense of the epithelium.
Consistent with this observation, quantification of KRT-
positive cells (Figure 2D, left) showed a decrease from
61.7% to 29.5% (P <0.001; n = 3), whereas the number of
VIM-positive cells (right) increased from 35.7% to 46.3%(P <0.001; n = 3) in Hmga2-KO mice when compared to
the WT mice. Immunostaining on sections of embryonic
lung showed increased levels of proliferation markers, spe-
cifically proliferating cell nuclear antigen (PCNA) and
antigen identified by monoclonal antibody Ki 67 (MKI67)
(Figure 2E and Additional file 1: Figure S1C), in both the
epithelium and the mesenchyme of the Hmga2-KO mice,
as shown by co-staining with antibodies specific for KRT
(left) or VIM (right), supporting our interpretation of the
histological analysis. However, quantification of our results
(Figure 2D) showed more prominent cell proliferation in
the mesenchyme (right), from 3.9% to 43.3% (P <0.001;
n = 3) when compared to the epithelium (left), from 8% to
23.6% (P <0.001; n = 3). To confirm increased cell proli-
feration in the embryonic lung after Hmga2-KO, we ana-
lyzed the expression of cell-cycle progression markers
cyclin E1, E2 and D2 (Figure 2F). Expression of these
genes increased after Hmga2-KO when compared to WT
mice, demonstrating elevated cell proliferation.
In addition to cell proliferation, programmed cell
death is an important process involved in lung develop-
ment [17]. Thus, we performed co-staining on sections
of embryonic lung (Figure 3A) using antibodies specific
Figure 2 Hmga2−/− mice embryonic lung showed increased cell proliferation. (A) Lungs of Hmga2-KO (−/−) embryo were smaller (top) and
showed a reduced lung-to-body-wet-weight ratio (bottom) when compared to WT (+/+) embryos at E18.5. Scale bars, 1 mm. Error bars show the SEM
(n = 6). ***P <0.001; **P <0.01; *P <0.05 after one-way analysis of variance. (B) Representative of histological analysis using hematoxylin and eosin stain
on sections of WT and Hmga2-KO embryonic lung at E18.5. Squares are shown at the bottom at higher magnification. Scale bars, 100 μm. (C) Sections
of embryonic lung (E18.5) of WT and Hmga2-KO mice were analyzed by confocal microscopy after double immunostaining using KRT- and VIM-specific
antibodies. Nuclear staining with DAPI (blue). Scale bars, 40 μm. (D) Quantification of proliferating (PCNA- or MKI67-positive) epithelial (KRT) and
mesenchymal (VIM) cells showed increased proliferation in both tissues of Hmga2-KO embryonic lung. Sections of embryonic lung (E18.5) of WT and
Hmga2-KO mice were treated as in E and used for quantification. Error bars show the SEM (n = 3). (E) Sections of embryonic lung (E18.5) of WT and
Hmga2-KO mice were analyzed as in C using (left) KRT- and PCNA-specific antibodies or (right) VIM- and MKI67-specific antibodies. Nuclear staining with
DAPI (blue). Scale bars, 40 μm. (F) Hmga2-KO enhanced expression of cell-cycle progression markers. Expression analysis of the indicated genes by
quantitative RT-PCR in E18.5 lung of WT and Hmga2-KO mice. Rel nor exp, relative expression normalized to Tuba1a. Error bars show the SEM (n= 4).
Asterisks as in A.
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tidase, cleaved caspase 3 (clCASP3) and KRT (left) or
the mesenchymal marker smooth muscle actin alpha 2(ACTA2, right). Quantification of clCASP3-positive cells
(Figure 3B) showed that whereas the level of apoptosis
in the mesenchyme was not significantly affected after
Figure 3 Hmga2 is required for proper differentiation of the distal epithelium. (A) Sections of embryonic lung (E18.5) of WT and Hmga2-KO
mice were analyzed as in Figure 2C using clCASP3- and KRT- (left) or ACTA2- (right) specific antibodies. Nuclear staining with DAPI (blue). Scale bars,
40 μm. (B) Quantification of clCASP3 positive epithelial (KRT) and mesenchymal (ACTA2) cells showed increased apoptosis in epithelial cells of
Hmga2-KO mice embryonic lung. Sections of embryonic lung (E18.5) of WT and Hmga2-KO mice were treated as in A and used for quantification. Error
bars show the SEM (n = 3). (C) Sections of embryonic lung (E18.5) of WT and Hmga2-KO mice were analyzed as in Figure 2C using (left) SFTPC- and
PCNA-specific antibodies or (right) SOX9- and PCNA-specific antibodies. Nuclear staining with DAPI (blue). Scale bars, 40 μm. (D) Quantification of
proliferating SFTPC- and SOX9-positive cells showed reduced differentiation and increased proliferation of progenitor cells in the distal epithelium of
Hmga2-KO mice embryonic lung. Sections of embryonic lung (E18.5) of WT and Hmga2-KO mice were treated as in C and used for quantification. Error
bars show the SEM (n = 3).
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increased in the lung epithelium of Hmga2−/− mice from
2.7% to 7.5% (P <0.01; n = 3), supporting the reduction
of epithelium when compared with WT mice. However,since this increase of apoptosis cannot account for the
drastic reduction of lung epithelium after Hmga2-KO,
we examined lung epithelium differentiation by ana-
lyzing the expression of proximal, Scgb1a1, and distal,
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Hmga2-KO mice (Additional file 1: Figure S1B). Whereas
Scgb1a1 expression did not change significantly, Sftpc ex-
pression was reduced after Hmga2-KO, suggesting defects
in distal epithelium differentiation. These defects were con-
firmed by immunostaining on sections of embryonic lung
(Figure 3C,D, left) that showed reduced numbers of
SFTPC-positive cells from 10.8% to 2.7% (P <0.001; n = 3)
after Hmga2-KO when compared with the WT mice. These
results were confirmed in lung explants after siRNA-
mediated Hmga2 knockdown (KD) (Additional file 2:
Figure S2A). To further investigate these results, we per-
formed immunostaining on sections of embryonic lung
using antibodies specific for the distal epithelium proge-
nitor cell marker sex determining region Y-box 9 (SOX9)
and PCNA (Figure 3C,D, right). The number of SOX9-
positive cells increased from 3.8% to 35.3% (P <0.001;
n = 3) after Hmga2-KO when compared with WT mice.
Interestingly, most of the SOX9-positive cells in the
Hmga2-KO lung were proliferating as shown by PCNA
co-staining. To summarize, Hmga2-KO increased cell pro-
liferation more significantly in the mesenchyme of the
embryonic lung, increased apoptosis in the epithelium,
and reduced differentiation of the distal airway epi-
thelium by altering the balance between progenitor cell
renewal and differentiation. Taking together, our data
support that Hmga2 is required for proper distal epithe-
lium differentiation.
Hmga2 knockout led to enhanced canonical WNT
signaling
Comparison of Hmga2−/− with Hmga2+/+ mice by Affyme-
trix microarray-based expression analysis of embryonic
lung (Figure 4A) revealed an increased expression of cell-
cycle-related genes, confirming our immunohistological
results. We found that transcripts of genes that are either
targets or positive regulators of canonical WNT signaling
pathway increased in the embryonic lung of Hmga2-KO
mice. Furthermore, expression of negative regulators of
canonical WNT signaling was reduced in Hmga2-KO
mice. These results indicate enhancement of canonical
WNT signaling after Hmga2-KO that was further validated
by increased activity of the beta-catenin/T-cell factor
(TCF)/lymphoid enhancer factor (LEF) WNT-reporter
(BAT-GAL) in embryonic lung of the BAT-GAL:Hmga2−/−
double transgenic mice when compared to BAT-GAL:
Hmga2+/+ (Figure 4B). Western blot analysis of embryonic
lung protein extracts (Figure 4C) showed increased levels of
activated-beta-catenin (ABC) and phosphorylation of the
WNT co-receptor low-density lipoprotein receptor-related
protein 6 (LRP6) [18-20] after Hmga2-KO, confirming en-
hancement of canonical WNT signaling. However, beta-
catenin (CTNNB1) has a dual role in both WNT signaling
and cell adhesion processes. To confirm enhanced WNTsignaling after Hmga2-KO, we analyzed the expression of
canonical WNT targets, Axin2, Mycn (v-myc myelocytoma-
tosis viral related oncogene), Fgfr2 (fibroblast growth factor
receptor 2) and Bmp4 (bone morphogenetic protein 4) in
the embryonic lung (Figure 4D). Expression of canonical
WNT targets increased after Hmga2-KO when compared
to WT mice, demonstrating elevated canonical WNT
signaling. Western blot analysis of protein extracts from
embryonic lung (Figure 4E) showed increased levels of ca-
nonical WNT targets after Hmga2-KO, confirming our ex-
pression analysis. Our results in the embryonic lung
of Hmga2−/− mice were supported by siRNA-mediated
Hmga2 depletion in the mouse lung epithelial cell line
MLE-12 (Additional file 3: Figure S3), which increased the
basal transcription of a co-transfected WNT-responsive
luciferase reporter (p3LEF-LUC) more than twofold when
compared to control siRNA (siCtrl)-transfected cells. In-
terestingly, forced expression of Hmga2 reduced the basal
transcription of p3LEF-LUC, thereby supporting an
Hmga2-mediated negative regulation of WNT signaling.
Enhanced canonical WNT signaling is related to cell
proliferation [21-23], correlating with our histological
and molecular characterization of the Hmga2-KO em-
bryonic lung. Nevertheless, we observed increased cell
proliferation in the mesenchyme of embryonic lung after
Hmga2-KO, although Hmga2 expression is restricted to
the distal epithelium of the embryonic lung. A plausible
explanation for these two observations could be that
enhanced WNT signaling after Hmga2-KO is induced
in part by diffusible positive regulators of canonical
WNT signaling. Indeed, our Affymetrix microarray-based
expression analysis (Figure 4A) showed elevated expres-
sion of Wnt11, Wnt7b and Wnt2b in embryonic lung
of Hmga2−/− mice when compared to Hmga2+/+. These
results were confirmed by qRT-PCR-based expression
analysis (Figure 4F). Furthermore, immunostaining on
sections of embryonic lung using CTNNB1-specific
antibody (Figure 4G) showed increased translocation of
CTNNB1 from the cytoplasm into the nucleus in cells of
both the epithelium and the mesenchyme after Hmga2-
KO, demonstrating elevated canonical WNT signaling in
both tissues and explaining hyperproliferation and ex-
pansion of the mesenchyme after Hmga2-KO.
To confirm the causal involvement of canonical WNT
signaling in mediating the effect of Hmga2-LOF, we used
an organ explant culture system that mimics the normal
embryonic lung development (Additional file 4: Figure
S4A,B) [24]. Depletion of Hmga2 in these organ explants
by siRNA treatment (Additional file 4: Figure S4C,D) led
to a marked impairment in branching morphogenesis
when compared to explants exposed to control siRNA
(siCtrl) (Figure 5A). These defects during the formation
of the bronchial and respiratory tree after Hmga2-KD
were validated by quantification of the total number of
Figure 4 Hmga2−/− mice embryonic lung showed enhanced canonical WNT signaling. (A) Enriched cellular pathways (P <0.05) after Affymetrix
microarray-based transcriptome analysis of Hmga2−/− E18.5 lung when compared to Hmga2+/+. Left, Kyoto Encyclopedia of Genes and Genomes pathway
analysis performed using DAVID bioinformatics tool. Green, reduced expression (fold change <1.2); magenta, increased expression (fold change ≥1.2); repli,
replication; ma, maturation; JAK-STA, Jak-STAT signaling; Toll lik, Toll-like-receptor signaling; RIG, RIG-like-receptor signaling. Right, Heat map was done using
DNAStar Arraystar 11.0 and represents expression of genes involved in the WNT signaling pathway in Hmga2+/+ and Hmag2−/− E18.5 lung. Green, low expression;
magenta, high expression; FC, fold change. (B) Hmga2-KO enhanced beta-catenin/TCF/LEF reporter activity in E14.5 lungs of the BAT-GAL transgenic mice.
Representative (n=5) BAT-GAL staining (blue color) shows activated WNT signaling. Scale bars, 2 mm. (C) Hmga2-KO increased levels of activated-beta-catenin
(ABC) and phosphorylated LRP6 (pLRP6). Protein extracts from WT or Hmga2-KO E18.5 lungs were analyzed by western blot using the indicated antibodies. Lanes
2 and 3 are biological duplicates. (D) Hmga2-KO enhanced expression of canonical WNT pathway markers. Expression analysis of the indicated genes as in
Figure 2F. (E) Hmga2-KO increased protein levels of canonical WNT pathway markers. Protein extracts were analyzed as in C using the indicated antibodies.
(F) Hmga2-KO enhanced expression of secreted WNT glycoprotein genes Wnt7b, Wnt2b and Wnt11. Expression analysis as in Figure 2F. (G) Hmga2-KO
increased nuclear localization of CTNNB1 in cells of the epithelium (epi) and the mesenchyme (mes) of the embryonic lung. Sections of E14.5 lung of WT
and Hmga2-KO mice were analyzed as in Figure 2C using KRT- and CTNNB1- specific antibodies. Square shows details at higher magnification on the right.
Nuclear staining with DAPI (blue). Arrows indicate nuclear CTNNB1. Dashed line shows epithelium-mesenchyme-boundary. Scale bars, 40 and 10 μm (right).
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Figure 5 Inhibition of canonical WNT signaling partially rescued the Hmga2 loss-of-function phenotype. (A) Embryonic lung explants
were cultured as in Additional file 4: Figure S4A. Explants were treated with control (siCtrl) or Hmga2-specific siRNAs (siHmga2) together with the
canonical WNT inhibitor DKK1 for 72 h till stage E15 equivalent (E15*). Scale bars, 500 μm. (B) Terminal branches (top) and total branch length
(bottom) were quantified at E12.5 and E15.5* Embryonic lung explants were treated as in A. Error bars show the SEM (n = 6). ***P <0.001;
**P <0.01; *P <0.05 after one-way analysis of variance. (C) Inhibition of canonical WNT signaling antagonized the effect of Hmga2-LOF. Protein
extracts from the lung explants treated as in A were analyzed by western blot using the indicated antibodies. LMNB1 was used as loading control.
(D) Expression analysis of the indicated genes by quantitative RT-PCR in embryonic lung explants that were treated as in A. Relative expression
normalized to Tuba1a. Error bars show the SEM (n = 3). Asterisks as B. (E) Protein extracts from the lung explants treated as in A were analyzed by
western blot using the indicated antibodies. TUBA1A was used as loading control.
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E12.5 lungs were cultured for 72 hours in the presence
of a Hmga2-specific siRNA (siHmga2), the total number
of terminal branches was reduced from 58 (siCtrl) to 34(P <0.001; n = 6), and the branch length from 17 mm
(siCtrl) to 12 mm (P <0.001; n = 6). However, treatment
of the explants with the secreted canonical WNT inhi-
bitor dickkopf homolog 1 (DKK1) [25] antagonized the
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the total number of terminal branches to 51 (P <0.01;
n = 6) and the branch length to 14 mm (P <0.01; n = 6).
DKK1 treatment alone also affected branching morpho-
genesis by blocking WNT signaling as previously de-
scribed from experiments in embryonic lung explants
[26]. Western blot analysis of protein extracts from em-
bryonic lung explants showed increased levels of ABC
and phosphorylated LRP6 after Hmga2-KD (Figure 5C,
lane 4), demonstrating enhanced canonical WNT sig-
naling that was antagonized after DKK1 treatment
(Figure 5C, lane 5). The partial rescue of the Hmga2-
LOF phenotype achieved by DKK1-mediated block of
WNT signaling was validated by expression analysis of
canonical WNT targets (Figure 5D) and by western blot
analysis of protein extracts from embryonic lung ex-
plants (Figure 5E). Our data demonstrated the causal
involvement of increased WNT signaling in mediating
the effect of Hmga2-LOF, suggesting a role of Hmga2
in negative regulation of WNT signaling that was
supported by reduced activity of the WNT-responsive
p3LEF-LUC reporter after Hmga2 over-expression in
MLE-12 cells (Additional file 3: Figure S3).Figure 6 HMGA2 directly regulates Gata6 and thereby modulates Fzd
same cells of the distal lung epithelium. Fluorescence microscopy of embryon
GATA6-specific antibodies. Nuclear staining with DAPI (blue). Square shows d
expression of Gata6 and its downstream target gene Fzd2. Expression analysis
normalized to Tuba1a. Data are presented as mean ± SEM (n = 4). ***P <0.001
WT (+/+) or Hmga2−/− embryonic lung (E18.5) were analyzed as in Figure 4C
Gata6 transcription. Top, Luciferase reporter assays of MLE-12 cells transiently
vector) or Hmga2 expression construct. RLU, relative light units. Bottom, Gata6
treated as above. Rel nor exp, relative expression normalized to Gapdh. Data a
HMGA2 binds to the endogenous Gata6 promoter. Top, in silico analysis of th
revealed several HMGA2 binding elements (squares). Arrows, position of the p
HMGA2-specific antibody or IgG (negative control). ChIP, chromatin-immunop
mean ± SEM (n = 4) and asterisks as in B.HMGA2 directly activates Gata6 expression
GATA6 is a transcription factor that is essential for
branching morphogenesis and inhibits canonical WNT
signaling in the distal epithelium of the lung by transcrip-
tional activation of its downstream target, the canonical
WNT-beta-catenin pathway antagonist Fzd2 [11,27]. The
defects observed after Hmga2-LOF were similar to the
Gata6-LOF phenotype (Additional file 2: Figure S2A,B)
[9]. Therefore, we investigated whether the enhancement
of canonical WNT signaling after Hmga2-LOF could in-
volve Gata6 and Fzd2. Immunostaining on sections of em-
bryonic lung (E14.5) using HMGA2- and GATA6-specific
antibodies (Figure 6A) showed the presence of both pro-
teins in the same cells of the distal lung endoderm. Inter-
estingly, expression analysis in embryonic lung showed
that Gata6- and Fzd2-transcripts decreased after Hmga2-
KO when compared to WT mice (Figure 6B). Consistently,
siRNA-mediated Hmga2-LOF reduced Gata6 and Fzd2
expression in embryonic lung explants (Additional file 2:
Figure S2B). Western blot analysis of protein extracts from
embryonic lung (Figure 6C) showed reduced levels of
GATA6 and FZD2 after Hmga2-KO, supporting our
expression analysis. To investigate the effect of Hmga22 expression. (A) HMGA2 and GATA6 co-localized in the nuclei of the
ic lung sections (E14.5) after double immunostaining using HMGA2- and
etails at higher magnification. Scale bars, 40 μm. (B) Hmga2-KO decreased
of the indicated genes as in Figure 4D. Rel nor exp, relative expression
; **P <0.01 after one-way analysis of variance. (C) Protein extracts from
using the indicated antibodies. (D) Hmga2 over-expression increased
transfected with a Gata6-Luc reporter plasmid and control (Ctrl, empty
expression was monitored by quantitative RT-PCR in MLE-12 cells
re presented as mean ± SEM (n = 4) and asterisks as in B. (E) Endogenous
e Gata6 gene (-631 to +1 base pairs relative to transcription initiation site)
rimers used for ChIP. Bottom, ChIP of the Gata6 promoter using
recipitation assay; IgG, immunoglobulin G. Data are presented as
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cells were transiently transfected with Hmga2 and a
plasmid containing the luciferase (Luc) reporter gene
under the control of the Gata6 promoter (Figure 6D, top).
Forced expression of Hmga2 increased more than fivefold
the basal transcription of the Gata6-Luc reporter. In
addition, expression of endogenous Gata6 increased more
than twofold after Hmga2 transfection (Figure 6D, bot-
tom). Consistently, in silico analysis of the murine Gata6
gene (Figure 6E, top) revealed several HMGA2 binding el-
ements near the transcription initiation site. Moreover,
chromatin immunoprecipitation assay (ChIP) in MLE-12
cells (Figure 6E, bottom) showed a direct association of
endogenous HMGA2 to the endogenous Gata6 promoter.
Thus, we conclude that HMGA2 directly activates Gata6
gene expression, and the enhanced WNT signaling caused
by Hmga2-LOF could also be mediated by a reduction of
the WNT signaling antagonizing proteins GATA6 and
FZD2.
To show the requirement of Gata6 in Hmga2-mediated
regulation of WNT signaling, we transfected MLE-12 cells
with Hmga2 after siRNA-mediated Gata6- or Fzd2-deple-
tion (Figure 7A). Expression analysis showed that Hmga2-
GOF increased the levels of Gata6 and Fzd2 but reduced
the levels of canonical WNT targets Mycn, Axin2 and
Bmp4, confirming a role of Hmga2 in inhibition of
canonical WNT signaling. Interestingly, Gata6- or Fzd2-
depletion antagonized the effect of Hmga2-GOF on both
groups of markers analyzed, indicating the requirement of
Gata6 and Fzd2 for the negative regulation of WNT sig-
naling mediated by Hmga2.
To determine the causal involvement of Gata6 in
Hmga2-mediated regulation of WNT signaling, we trans-
fected MLE-12 cells with Gata6 after siRNA-mediated
Hmga2- or Fzd2-depletion (Figure 7B and Additional file 3:
Figure S3B). Expression analysis showed that Hmga2- and
Fzd2-LOF enhanced the expression of canonical WNT
targets, supporting our previous expression analysis in the
embryonic lung of Hmga2-KO mice and as expected from
WNT signaling antagonizing genes. Interestingly, Gata6
transfection compensated the effect of Hmga2-LOF, but
not of Fzd2-LOF. Our data indicate that Gata6 acts down-
stream of Hmga2 and upstream of Fzd2 in negative regu-
lation of WNT signaling (Figure 7C).
Discussion and conclusions
We showed that Hmga2 is expressed in the embryonic
mouse lung at the distal airways. Hmga2 mRNA levels
were high during early stages of lung development, in
which cells are undifferentiated, and decreased as lung
development progressed, coincident with cell differen-
tiation. Interestingly, we detected a slight increase of
Hmga2 expression at E18.5 that matches with the estab-
lishment of a bipotent progenitor cell population in thedistal epithelium [28]. Our data correlate with previous
reports where HMGA2 was shown to be present at high
levels in various undifferentiated tissues during embry-
onic development and in strongly reduced levels in the
corresponding adult tissues [12-15].
Hmga2-KO induces a pygmy phenotype due to re-
duced expression of insulin-like growth factor 2 mRNA
binding protein 2 (Igf2bp2) [15,16,29]. Prior to our study,
the lung of Hmga2−/− mice had not been analyzed. De-
tailed analysis of Hmga2−/− mice showed that Hmga2 is
required for distal epithelium differentiation during em-
bryonic lung development. Hmga2-KO led to enhanced
canonical WNT signaling due to an increase of secreted
WNT glycoproteins as well as a reduction of the WNT
signaling antagonizing proteins GATA6 and FZD2,
thereby supporting that Hmga2 regulates WNT signaling
at different points of the pathway (Figure 7C). The cau-
sal involvement of canonical WNT signaling in media-
ting the effect of Hmga2-LOF was demonstrated by the
DKK1-induced rescue of Hmga2-LOF in embryonic lung
explants (Figure 5A-E). HMGA2-mediated regulation of
Gata6 seems to be a key process in fine-tuning the acti-
vity of canonical WNT signaling in airway epithelium.
The sequential order of events suggested in our model
(Figure 7C) in which Hmga2 acts upstream of Gata6 is
strongly supported by the fact that HMGA2 directly
regulates Gata6 (Figure 6A-E) as well as by the Gata6-
mediated rescue experiments of Hmga2-LOF in MLE-12
cells (Figure 7B). Since HMGA2 regulates the transcrip-
tion of its target genes by modulating the chromatin
structure and by recruiting other proteins to the tran-
scription regulatory complex [12], the scope of our fu-
ture work will be to investigate in detail the mechanism
of HMGA2-mediated transcriptional regulation of the
Gata6 promoter.
Hmga2-KO increased cell proliferation not only in the
lung epithelium, where Hmga2 is expressed, but also in
the mesenchyme, suggesting a paracrine effect that could
be explained by increased expression of the secreted
components of WNT signaling. Since HMGA2 is known
to activate transcription, the increased expression of
Wnt2b, Wnt7b and Wnt11 after Hmga2-KO suggest the
participation of a transcription inhibitor that could block
the expression of these secreted components of WNT
signaling and whose expression could be regulated by
HMGA2 (Figure 7C). Identification of this unknown
mediator of HMGA2 will be the scope of future studies.
Interestingly, analysis of the Wnt7b promoter showed that
deletion of the region between -1,005 bp and -829 bp
relative to the second transcription start site significantly
increased the basal transcription activity of a Wnt7b-lucif-
erase reporter [30], suggesting that the binding element
of a putative transcription inhibitor was deleted in this
construct.
Figure 7 Hmga2 acts upstream of Gata6 in WNT signaling regulation. (A) Gata6 and Fzd2 are required for the effect of Hmga2 GOF on
expression of WNT targets. Expression analysis of the indicated genes by quantitative RT-PCR in MLE-12 cells that were transfected with either control
(Ctrl) or Gata6- or Fzd2-specific siRNA and Hmga2 expression plasmid as indicated. Data are presented as mean ± SEM (n = 4). ***P <0.001; **P <0.01;
*P <0.05 after one-way analysis of variance. (B) Gata6-GOF rescued the effect of Hmga2-LOF on expression of WNT targets. Expression analysis of the
indicated genes by quantitative RT-PCR in MLE-12 cells that were transfected with either control (Ctrl) or Hmga2- or Fzd2-specific siRNA and Gata6
expression plasmid as indicated. Data are presented as mean ± SEM (n = 4) and asterisks as in A. (C) Model. Hmga2 regulates WNT signaling at different
points of the pathway. Regulation of the secreted WNT glycoproteins (Wnt2b, Wnt7b and Wnt11) mediates the paracrine effect on the mesenchyme of
the embryonic lung. In addition, HMGA2-mediated regulation of Gata6 is a key process in fine-tuning the activity of canonical WNT signaling in
developing airway epithelium. X, unknown transcription factor.
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onic lung explants are very similar (Additional file 2:
Figure S2A,B) [9]. However, the milder phenotype ob-
served in the embryonic lung of Hmga2-KO mice when
compared either with the Gata6-KO or the phenotype in-
duced after Hmga2-KD in embryonic lung explants might
be explained by redundancy in the function between
Hmga2 and Hmga1, another member of the HMG protein
family. Hmga1 transcript was reduced after Hmga2-LOF(Additional file 4: Figure S4C) but not affected in the
Hmga2-KO mice (Additional file 1: Figure S1B). Hmga1
might compensate the Hmga2-KO, thereby avoiding
lethality at early embryonic stages, as is the case after
Gata6-KO [31,32], or soon after birth due to defects in
the lung, as is the case after lung epithelium-specific abla-
tion of Gata6 [11]. In addition, the expansion of the
mesenchyme in the embryonic lung after Hmga2-KO and
the apparent increase of epithelium in embryonic lung
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ferences of both LOF systems. In the transgenic approach,
Hmga2-LOF takes place soon after fertilization and affects
lung development from the initial stages of lung bud forma-
tion; in the explant culture, the LOF starts at E12.5, thereby
reducing the rather indirect effect on the mesenchyme and
making the effect on the epithelium more dominant. Ana-
lysis of the lungs in inducible and conditional double
transgenic mice (Hmga2−/−:Hmga1−/−) would test these hy-
potheses and should be the scope of future studies.
Hmga2 expression is positively regulated by transfor-
ming growth factor beta 1 signaling [33]. In addition, our
data show that Hmga2 antagonizes canonical WNT sig-
naling. Therefore, it will be of interest to determine a
potential opposing effect between these two signaling
pathways in establishing the proximal-distal axis during
branching morphogenesis and lung epithelium differen-
tiation in the developing lung. Hmga2 might play a crucial
role on the interplay between these signaling pathways.
Organ regeneration requires a proper balance between
self-renewal and differentiation of tissue-specific progeni-
tor cells. Canonical WNT signaling has been implicated in
different regenerative processes including zebrafish tail re-
generation, zebrafish cardiac regeneration and expansion
of anterior heart field progenitors in mammals [34,35].
Moreover, canonical WNT signaling is activated upon
lung epithelial regeneration, and enhanced WNT activity
caused by lung epithelium-specific ablation of Gata6 led
to a premature and increased number of BASCs [11].
BASCs represent one of several regional progenitor cell
populations in the adult lung and are responsible for re-
generation of bronchiolar and alveolar epithelium during
homeostatic turnover and in response to injury [4,36].
Our study suggests the possible role of Hmga2 in the adult
lung controlling the balance between BASC expansion
and differentiation. Our results are the starting point for
future studies in which the relevance of Hmga2-mediated
regulation of WNT signaling might be investigated in the
adult lung within the context of proper balance between
differentiation and self-renewal of lung stem/progenitor
cells and lung regeneration during both homeostatic
turnover and repair after injury. Characterization of the
regulatory mechanisms controlling the proper balance
between expansion and differentiation of lung stem/pro-
genitor cells will have a profound impact on our under-
standing and treatment of lung disease.
Methods
Animal experiments
Mouse work was performed in compliance with the
German Law for Welfare of Laboratory Animals. The
permission to perform the experiments presented in
this study was obtained from the Regional Council
(Regierungspräsidium in Darmstadt, Germany). Thenumbers of the permissions are IVMr46-53r30.03.
MPP04.12.02 and IVMr46-53r30.03.MPP06.12.01. Ani-
mals were killed for scientific purposes according to the
law mentioned above, which complies with national and
international regulations.
C57BL/6 and Hmga2+/− mice (stock # 002644, Jackson
Laboratories) [37] were obtained from Charles River
Laboratories (Germany) at 5 to 6 week of age. BAT-GAL
transgenic reporter mice (also called beta-catenin/TCF/
LEF reporter transgenic mice) were obtained as a gift from
Prof. Stefan Liebner [38]. BAT-GAL:Hmga2−/− double
transgenic embryos were obtained by crossing heterozy-
gous BAT-GAL:Hmga2+/− mice. Animals were housed
and bred under controlled temperature and lighting (12/
12-hour light/dark cycle), fed with commercial animal feed
and water ad libitum. All experiments were performed
with mouse embryonic lungs. Timed-pregnant C57BL/6
WT mice were killed at indicated time points; embryonic
lungs were isolated according to standard methods and
whole-mount in situ hybridization was performed as de-
scribed [39] with minor modifications. Briefly, to synthesize
digoxigenin-labeled RNA probes, pcDNA3-mHmga2 plas-
mid (gift from Prof. Peter Grouse) [40] was linearized, and
UTP-digoxigenin (Roche) substituted antisense RNA
probes were transcribed with T7 RNA polymerase. Sense
RNA probes as negative control were transcribed with SP6
RNA polymerase.
Embryonic lung explants culture
Lungs of timed-pregnant C57BL/6 WT mice were dis-
sected from the embryos at E12.5 and cultured for
72 hours till E15.5 equivalent (E15.5*) as previously re-
ported [24]. The explants were treated with 3 μM siRNAs
against Hmga2 (Applied Biosystems, Silencer Select
siRNAs, Assay ID s67600), scrambled siRNA (negative
control, Ctrl) (Sigma, MISSION siRNA Universal Negative
Control, SIC001) or 200 nM of mouse recombinant
DKK1 (R&D Systems, 5897-DK-010) following a similar
protocol as previously described [9,41-44]. The siRNA
and protein treatments were renewed every 24 hours.
After 72 hours, the lungs were checked for morphological
changes by standard microscopy techniques and harvested
for RNA (QIAGEN RNeasy Micro Kit) and protein isola-
tion. The images were used to determine the total number
of terminal bud branches and for quantification of total
branch length as described [45].
Cell culture transfection assays
Mouse lung epithelial cells (MLE-12, ATCC CRL-2110)
were cultured following the supplier’s instructions. MLE-12
cells were transiently transfected either with 40 nM siCtrl
(negative control; AM4611, Ambion), 40 nM siGata6
(L-065585-00, Dharmacon), 20 nM siFzd2 (s81164, Applied
Biosystems), 20 nM siHmga2 (s67600, Applied
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pCMV6-entry-Gata6-flag/myc or pBL (Ctrl) as indicated
using Lipofectamine 2000 transfection reagent (Invitro-
gen) at a ratio of 1:2 DNA:Lipofectamine. Cells
were harvested 48 hours later for further analysis.
The proximal 631 bp Gata6 promoter was amplified
and cloned into the pGL4basic vector to generate pGL4-
Gata6 promoter luciferase vector. Dual-luciferase reporter
assays (Promega) were performed as described [46] fol-
lowing transient transfection of MLE-12 cells in 96-well
plates with 20 nM effector siRNAs and a total of 100 ng
DNA per well, containing 15 ng effector plasmid, 15 ng
pGL4-Gata6 promoter or p3LEF-LUC luciferase reporter
plasmid, 1 ng Renilla luciferase reporter plasmid and
69 ng pBluescript. Each sample was performed in tripli-
cate. Each experiment was repeated at least three times.
Affymetrix microarrays, quantitative PCR and ChIP assays
Total RNA was isolated with RNeasy® plus mini kit (Qiagen)
and quantified using a spectrophotometer. Affymetrix
microarray-based transcriptome analysis of Hmga2−/− and
Hmga2+/+ embryonic lung (E18.5) was performed and an-
alyzed as described [47]. Kyoto Encyclopedia of Genes and
Genomes pathway enrichment based analysis of dysre-
gulated pathways in Hmga2−/− versus Hmga2+/+ was done
using DAVID software [48] and generation of fold change
and Heat map were performed using DNAStar Arraystar
11.0. The data discussed in this publication have been
deposited in NCBI’s Gene Expression Omnibus [49]
through accession number [GEO:GSE55340] (http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55340).
The High Capacity Reverse Transcription kit (Applied
Biosystems) was used for synthesis of cDNA from total
RNA. Quantitative real-time PCR reactions were per-
formed using SYBR® Green on the Step One plus Real-
time PCR system (Applied Biosystems). The PCR results
were normalized with respect to the housekeeping gene
for tubulin alpha 1a (Tuba1a) or glyceraldehyde-3-phos-
phate dehydrogenase (Gapdh).
ChIP analysis of the mouse Gata6 promoter was per-
formed as described [50] with slight modifications. Briefly,
MLE-12 cells were cross-linked by 1% formaldehyde for
10 minutes, lysed, and sonicated with Diagenode Bio-
rupter to an average DNA length of 500 to 600 bp. After
isolation, the soluble chromatin was immunoprecipi-
tated with immunoglobulin G (control, Santa Cruz) or
HMGA2-specific antibody (sc-30223; Santa Cruz Biotech-
nology). Reverse cross-linked immunoprecipitated chro-
matin was subjected to qPCR using the primers listed in
Additional file 5: Table S1.
Immunohistochemistry
For paraffin-embedded mouse embryonic lung tissue,
lungs were fixed overnight in 1% paraformaldehyde at4°C, dehydrated over a graded series of alcohol, and paraf-
fin embedded. Sections of 4 μm were prepared on a
microtome (Leica). Antigen retrieval was performed by
microwave heating for 8 minutes using 1 mM EDTA
(pH 8) or 1 mM citrate buffer (pH 6). For cryosections of
mouse lung tissue, lungs were harvested and embedded in
polyfreeze tissue freezing medium (Polysciences). Sections
of 10 μm were prepared on a cryostat (Leica). Sections
were post-fixed in 4% paraformaldehyde for 10 minutes.
Antibody staining was performed following standard pro-
cedures. All incubations and washes were performed with
histobuffer containing 3% bovine serum albumin and 0.2%
Triton X-100 in 1× phosphate-buffered saline, pH 7.4.
Non-specific binding was blocked by incubating with
donkey serum and histobuffer (1:1 (v/v) ratio) for 45 to
60 minutes. The sections were then incubated with pri-
mary and secondary antibodies for 60 minutes followed by
nuclear staining. The sections were examined with a
confocal microscope (Zeiss) or fluorescent microscope
(Leica). Antibodies used were specific against HMGA2
(BioCheck), LMNB1 (Santa Cruz), GATA6 (R&D system),
cadherin 1 (Abcam), VIM-Cy3 (Sigma), PCNA (Santa
Cruz), MKi67 (Abcam), KRT (Dako and Sigma), Pro-
SFTPC (Millipore), SOX9 (Santa Cruz), ABC (Millipore),
CTNNB1 (Abcam), ACTA2-Cy3 (Sigma) and clCASP3
(Cell Signaling). Secondary antibodies used were Alexa
488, Alexa 633 and Alexa 555 (Invitrogen). DAPI (Invitro-
gen) were used as nuclear dye.
Paraformaldehyde-fixed and paraffin-embedded lung
tissue sections were stained with hematoxylin and eosin
and used for the lung morphology analysis. Figures were
elaborated following a color scheme recommended to
make them visible and easy to interpret by people with
all types of color vision [51,52].
Western blot
Western blotting was performed following standard pro-
tocols and using antibodies specific for HMGA2 (Bio-
check and Santa Cruz), TUBA1A (Sigma), GATA6 (R&D
system), FZD2 (Abcam), active-beta-catenin (ABC, Milli-
pore), LRP6 (Cell signaling), phosphorylated LRP6 (Cell
signaling), AXIN2 (Abcam), BMP4 (Millipore), MYCN
(Santa Cruz) and LMNB1 (Santa Cruz). Immunoreactive
proteins were visualized with the corresponding horsera-
dish peroxide-conjugated secondary antibodies using the
Super Signal West Femto detection solutions (Thermo
Scientific). Signals were detected and analyzed with Lumi-
nescent Image Analyzer (Las 4000, Fujifilm).
Statistical analysis
In total, the lungs of six Hmga2−/− mice were analyzed
using different techniques. The lungs of six Hmga2+/+
were used as control because the heterozygote Hmga2+/−
mice presented a mild phenotype. With the exception of
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ments were performed at least three times and the sam-
ples in each experiment were analyzed in triplicates. The
Affymetrix array-based expression analysis was performed
one time using biological duplicates. Statistical analyses
were performed using Excel Solver. All data are re-
presented as mean ± SEM. One-way analyses of variance
(ANOVA) were used to determine the levels of difference
between the groups and P values for significance.
Additional files
Additional file 1: Figure S1. Characterization of embryonic lung in
Hmga2−/− mice. (A) Top, Hmga2−/− mouse embryos at E18.5 were
smaller than WT embryos. Main interval of the scale is equivalent to
1 cm. Bottom, Hmga2−/− embryo showed 40% body wet weight
reduction when compared to WT embryos. Data are represented as
mean ± SEM (n = 3). ***P <0.001; **P <0.01; *P <0.05. (B) Expression
analysis of the indicated genes by qRT-PCR in embryonic lung (E18.5) of
WT and Hmga2−/− mice. Rel nor exp, relative expression normalized to
Tuba1a.; Scgb1a1, secretoglobin 1A1 also known as CC10; Sftpc,
surfactant-associated protein C also known as SPC. Error bars, SEM (n = 4).
Asterisks as in A. (C) Sections of embryonic lung (E18.5) of WT (+/+) and
Hmga2−/− mice were analyzed by confocal microscopy after double
immunostaining using (left) MKI67- and CDH1-specific antibodies or
(right) PCNA- and VIM-specific antibodies. Nuclear staining with DAPI
(blue). Scale bars, 40 μm.
Additional file 2: Figure S2. Hmga2 and Gata6 loss-of-function in
embryonic lung explants led to a marked impairment of airway epithelial
differentiation due to enhanced canonical WNT activity. (A) Hmga2-KD in
lung explants led to dilated airways and resulted in lung epithelial
differentiation defects. Phenotype of Gata6-KD in lung explants was
similar to the Hmga2-KD. Top, embryonic lungs were explanted and
cultured until E15.5* as in Additional file 4: Figure S4A. Explants were
treated with control (siCtrl), Hmga2- (siHmga2) or Gata6- (siGata6) specific
siRNAs. Scale bars, 500 μm. Bottom, sections of treated explants were
analyzed by confocal microscopy after immunostaining using either
SFTPC- or with ABC-specific antibodies as indicated. Nuclear staining with
DAPI (blue). ABC, activated-beta-catenin. Scale bars, 40 μm. (B) Hmga2 or
Gata6 knockdown enhanced expression of canonical WNT pathway
markers and reduced Fzd2 expression. Expression analysis of the indicated
genes as in Additional file 4: Figure S4C. Gene expression normalized to
Tub1a1. Fzd2, frizzled homolog 2; Fgfr2, fibroblast growth factor receptor 2.
Error bars, SEM (n = 4). ***P <0.001; **P <0.01; *P <0.05.
Additional file 3: Figure S3. Hmga2 depletion increased the
transcription of a WNT-responsive reporter whereas Hmga2 forced
expression reduced it. (A) Luciferase reporter assays of MLE-12 cells
transiently transfected with a p3LEF-LUC reporter plasmid and control
(Ctrl) or Hmga2 specific siRNA (siHmga2); or Hmga2 expression construct;
or treated with lithium chloride (LiCl, positive control). Error bars, SEM
(n = 3). (B) Gata6-GOF rescued the effect of Hmga2-LOF on expression of
WNT targets. Expression analysis of the indicated genes by qRT-PCR in
MLE-12 cells that were transfected with either control (Ctrl) or Hmga2- or
Fzd2-specific siRNA and Gata6 expression plasmid as indicated. Data are
represented as mean ± SEM (n = 4). ***P <0.001; **P <0.01; *P <0.05.
Additional file 4: Figure S4. Hmga2 loss-of-function in embryonic lung
explants led to a marked impairment of airway epithelial differentiation
due to enhanced canonical WNT activity confirming the results obtained
in Hmga2−/− mice. (A) Schematic diagram of embryonic lung explant
culture experiments. Mice embryonic lungs were explanted at E12.5,
cultured for 72 hours until E15.5* and harvested for gene expression
analysis and immunostaining. Scale bars, 500 μm. (B) Embryonic lung
explant cultures mimic the normal embryonic lung development.
Expression analysis of the indicated genes by qRT-PCR in embryonic
lungs (E12.5, E15.5) and in explanted lungs (E15.5*) as in A. Rel nor exp,
relative expression normalized to Tub1a1. Data are represented asmean ± SEM (n = 4). (C) siRNA-mediated Hmga2-LOF was efficient in lung
explants. Embryonic lungs were explanted and cultured until E15.5* as in
A. Explants were treated with control (siCtrl) or Hmga2-specific (siHmga2)
siRNAs. Expression of the indicated genes was analyzed by qRT-PCR. Rel
nor exp, relative expression normalized to Tub1a1. Error bars, SEM (n = 4).
***P <0.001; *P <0.05. (D) Lung explants were treated with siRNAs as in C.
Protein extracts of treated explants were analyzed by western blot using
HMGA2-, ABC- or TUBA1A-specific antibodies. (E) Hmga2-KD enhanced
the activity of the beta-catenin/TCF/LEF reporter in lung explants of the
BAT-GAL transgenic mice. Lung explants of BAT-GAL mice were cultured
as in A. Explants were treated with control (siCtrl) or Hmga2-specific siRNAs
(siHmga2) or with lithium chloride (LiCl, positive control). Beta-galactosidase
staining was performed with the treated explants to detect activated WNT
signaling (blue color). Scale bars, 500 μm.
Additional file 5: Table S1. Oligonucleotide sequences used for real-time
qPCR and ChIP.
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